Pityriasis Clinical Trials Pityriasis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)
Condition:   Pityriasis Rubra Pilaris Intervention:   Drug: Ixekizumab Sponsors:   Oregon Health and Science University;   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2018 Category: Research Source Type: clinical trials